|
Nashville, Tenn., October 15, 2001 – Renal Care Group, Inc. (Nasdaq/NM:RCGI) today announced that its Board of Directors has approved plans to transfer Renal Care Group's listing to the New York Stock Exchange (NYSE).
Renal Care Group has filed an application with the NYSE and trading is expected to begin on Tuesday, November 13, 2001, under the ticker symbol "RCI." Until that time, the Company will continue to trade on the Nasdaq National Market.
Mr. Sam Brooks, chairman and chief executive officer of Renal Care Group, said, "Our listing on the New York Stock Exchange is a major milestone for Renal Care Group. It highlights the success the Company has achieved in implementing its growth strategy while focusing on cash flow and keeping our balance sheet strong. We are pleased with the value our shareholders have received from their investment, and we believe that listing on the New York Stock Exchange will broaden the liquidity of Renal Care Group shares, further enhancing that investment."
"We're privileged and honored to welcome Renal Care Group to the New York Stock Exchange," said Dick Grasso, NYSE chairman and chief executive officer. "As a leader in its industry, Renal Care Group is built on a foundation of commitment to improving the health of its patients and is dedicated to the principles of excellence, respect and integrity. We look forward to an outstanding partnership with Renal Care Group and its shareholders."
Renal Care Group, Inc. is a dialysis services company that provides care to patients with kidney disease. The Company currently treats approximately 17,900 patients through 225 owned outpatient dialysis facilities, in addition to providing acute dialysis services to more than 118 hospitals. Over 5,000 associates provide services across the Company's 26-state network.
Certain statements in this press release constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect management's expectations and are based on currently available information. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of Renal Care Group to differ materially from those expressed or implied by the forward-looking statements, including risks related to the integration of acquired companies. These and other factors are discussed in more detail in the Company's reports filed with the Securities and Exchange Commission, including without limitation, Renal Care Group's annual report on Form 10-K for the year ended December 31, 2000, and its quarterly reports on Form 10-Q for the quarters ended March 31, 2001 and June 30, 2001. Copies of these filings are available from Renal Care Group upon request.
Contact: R. Dirk Allison
Chief Financial Officer
615-345-5500 |
Press Releases